Anastassiou Gerasimos, Rebmann Vera, Wagner Stephan, Bornfeld Norbert, Grosse-Wilde Hans
Eye Clinic, University Clinic, Essen, Germany.
Invest Ophthalmol Vis Sci. 2003 May;44(5):2016-9. doi: 10.1167/iovs.02-0810.
Because the expression of classic and nonclassic HLA antigens is crucial for the recognition and elimination of tumor cells by cytotoxic T and/or NK cells, we analyzed the HLA-A, -B, -C, and -G expression in uveal melanoma specimens from 18 patients.
Tumor specimens and EDTA plasma samples from 18 patients treated by primary enucleation or tumor resection for primary uveal melanoma in the University Eye Clinic, Essen, Germany, were collected immediate after surgery. After solubilization of tumor tissue and specific immunoprecipitation of classic HLA-A, -B, and -C and nonclassic HLA-G antigens the tumor samples were analyzed by one-dimensional isoelectric focusing (1D-IEF) and Western blot analysis. In parallel, patients were typed for HLA-A, -B, and -C class I antigens by PCR with sequence-specific primers (PCR-SSP). In addition, HLA-A2 and -G expression was investigated by immunohistochemistry in paraffin-embedded tumor sections from these patients.
In 9 (50%) of 18 specimens, a full HLA-A and -B antigen expression pattern was detected by 1D-IEF. In six (33.3%) tumor specimens, an HLA class I allotype was missing (HLA-A2, -A28, -A29, -B18, -B35, and -B55), in two cases a haplotypic loss (HLA-A2, -B44 and HLA-A2, -B13) and in another case an allotype-specific loss combined with a haplotypic loss (HLA-A26, -A32, -B41) were observed. HLA-C and -G antigens were not detectable in any of the tumor samples by biochemical methods used.
A considerable portion of the uveal melanomas tested showed a loss of classic HLA class I antigens, which may enable them to escape from the immunosurveillance of cytotoxic T cells. HLA-C and -G antigens were not found in uveal melanoma tissue implying a susceptibility for NK lysis.
由于经典和非经典 HLA 抗原的表达对于细胞毒性 T 细胞和/或 NK 细胞识别和清除肿瘤细胞至关重要,我们分析了 18 例葡萄膜黑色素瘤标本中 HLA - A、-B、-C 和 -G 的表达情况。
在德国埃森大学眼科诊所,对 18 例因原发性葡萄膜黑色素瘤接受初次眼球摘除术或肿瘤切除术治疗的患者,术后立即收集肿瘤标本和 EDTA 血浆样本。在溶解肿瘤组织并对经典 HLA - A、-B 和 -C 以及非经典 HLA - G 抗原进行特异性免疫沉淀后,通过一维等电聚焦(1D - IEF)和蛋白质印迹分析对肿瘤样本进行分析。同时,采用序列特异性引物聚合酶链反应(PCR - SSP)对患者进行 HLA - A、-B 和 -C Ⅰ类抗原分型。此外,通过免疫组织化学方法研究这些患者石蜡包埋肿瘤切片中的 HLA - A2 和 -G 表达情况。
在 18 个标本中的 9 个(50%)中,通过 1D - IEF 检测到完整的 HLA - A 和 -B 抗原表达模式。在 6 个(33.3%)肿瘤标本中,一种 HLA Ⅰ类同种异型缺失(HLA - A2、-A28、-A29、-B18、-B35 和 -B55),在 2 例中观察到单倍型缺失(HLA - A2、-B44 和 HLA - A2、-B13),在另一例中观察到同种异型特异性缺失并伴有单倍型缺失(HLA - A26、-A32、-B41)。通过所使用的生化方法,在任何肿瘤样本中均未检测到 HLA - C 和 -G 抗原。
相当一部分被检测的葡萄膜黑色素瘤显示经典 HLA Ⅰ类抗原缺失,这可能使它们能够逃避细胞毒性 T 细胞的免疫监视。在葡萄膜黑色素瘤组织中未发现 HLA - C 和 -G 抗原,这意味着其对 NK 细胞裂解敏感。